Formulazioni di risankizumab ad alta concentrazione
Swiss patent · CH722597 · In force
Register entry
- Publication number
- CH722597
- Application number
- CH000865/2026
- Kind
- Swiss patent
- Status
- In force
- Specification
- Application, without search report
- Filed
- Dec 19, 2024
- Published
- Aug 1, 2026
- Protection ends at the latest
- Dec 18, 2044
- Next annual fee due
- Dec 31, 2027
- IPC classes
- A61K 39/395 (2006.01)
- Priority
- US 63/612,905 20.12.2023US 63/612,928 20.12.2023
- PCT application
- PCT/US2024/061124 19.12.2024
- PCT publication
- WO2025/137347 26.06.2025
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Specification status
- Specification status
- Non-published patent application → Patent application without search report
- Publication date
- 01.08.2026
Published in Swissreg on 01.08.2026
Parties
Holder
Inventor
Chen Wang
North Chicago, IL 60064, US
Georgeen Gaza-Bulseco
North Chicago, IL 60064, US
Johanna Lindermuth Gervais
North Chicago, IL 60064, US
Jie Wang
North Chicago, IL 60064, US
Eva-Maria Knoch
67061 Ludwigshafen, DE
Isabelle Deimel
67061 Ludwigshafen, DE
Katharina Kaleta
67061 Ludwigshafen, DE
Michael Siedler
67061 Ludwigshafen, DE
Xue Mi
North Chicago, IL 60064, US
Lihua Yang
North Chicago, IL 60064, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.